StockStory8d agoneutral
MRK Q3 deep dive: oncology launches, clinical pipeline advances, and margin headwindsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MarketBeat55d agoneutral
Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive Transformation